Human Adverse Hepatobiliary Effects Suite*
Request Licensing Information
- Models to support decision-making processes on hepatobiliary effects of pharmaceutical like chemicals.
- The endpoints covered by this suite of models include:
- Bile duct disorders
- Gall bladder disorders
- Liver jaundice disorders
- Liver acute damage disorders
- Liver enzyme release disorders
- Applicability domain defined by nearest neighbor analysis - explicit comparison of structural feature representations and coverage of test sets vs. the model
- Stand-alone product with read-only models
- Test structures entered in SMILES or MOL/SDF formats
- Batch predictions
- Windows XP or Vista with at least a Pentium 4, 1.0GHz processor (or equivalent) with Minimum 1.0 GB of RAM and 1 GB of disk space
Shopping Cart
0 items